RCT of the Clinical and Cost Effectiveness of Cognitive Behaviour Therapy (CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm (eDASH)

January 16, 2018 updated by: University of Nottingham

Randomised Controlled Trial of the Clinical and Cost Effectiveness of NICE Recommended Problem Solving Cognitive Behaviour Therapy (PS CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm

A randomized controlled trial to test the whether remote delivery of cognitive based therapy (CBT) is clinically and cost effective when compared to treatment as usual in adolescents and young adults with depression who self-harm.

Study Overview

Detailed Description

Self harm is one of the five leading causes of admission to acute hospital with rates increasing by nearly 50% from 2003-2009 (South West Public Health Observatory, 2012). Re-admission within 30 days is frequent. People who repeatedly self harm are at high risk for suicide and and as a result suicide, self-harm and crisis are priorities for CCGs and HWBs in the East Midlands.

The NICE Clinical Guideline 133 on longer-term treatment of self-harm recommends between 3 to 12 sessions of psychological treatment involving problem solving and alternative coping. Presently however, the biggest at risk group for self-harm and suicide is not offered any psychological treatment.

Studies have shown that mobile phones are a highly acceptable method of engaging adolescents with depression in psychological treatments such as CBT (Whittaker et al 2012). Furthermore a systematic review has show that treatment delivery via remote technology is just as effective as face-to-face in people with anxiety or depression (Bee et al, 2008).

The study therefore has the following aims and objectives:

  1. To optimise and determine the acceptability and feasibility of engaging and retaining patients with depression who repeatedly self-harm in a remotely delivered (through video calling/telephone) CBT intervention over 10 sessions.
  2. To outline the barriers and drivers to delivering both the study and the remotely delivered PS CBT intervention and how barriers to the interventions are addressed through a network of practice or other means.
  3. If the recruitment and retention into the study and the remotely delivered PS therapy are feasible and acceptable, then we will determine the clinical effectiveness and cost effectiveness of the intervention versus treatment as usual.
  4. If the intervention (pilot study) proves to be clinically effective and cost effective then the barriers and drivers to implementation in all counties in the East Midlands will be explored using a network of practice linking with NHS organisations, strategic clinical networks, and the AHSN (see qualitative analysis of barriers and drivers to the implementation of the intervention below).

The main hypothesis of this study is:

Adolescents and young adults who receive problem solving cognitive behaviour therapy (plus treatment as usual) will report greater reduction in their depressive symptoms (as measured using Beck depression inventory 2) from baseline to 6 months in comparison to those receiving treatment as usual.

Secondary objectives will be to observe a change over 12 months on measures of depression, hopelessness and suicidality.

Study configuration:

This study will compare two groups: participants will be randomly assigned to the TAU group (control group) or the remotely delivered PS CBT (and TAU) group (intervention group).

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Derbyshire
      • Derby, Derbyshire, United Kingdom, DE22 3LZ
        • Derbyshire Healthcare NHS Foundation Trust
      • Derby, Derbyshire, United Kingdom, DE22 3NE
        • Derbyshire Hoispitals NHS Foundation Trust
    • Deryshire
      • Chesterfield, Deryshire, United Kingdom, S44 5BL
        • Chesterfield Royal Hospital NHS Foundation Trust
    • Nottinghamshire
      • Nottingham, Nottinghamshire, United Kingdom, NG3 6AA
        • Nottinghamshire Healthcare NHS foundation Trust.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 30 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • >2 self-harm episodes.
  • With high levels of unipolar depressive symptoms (BDI-2 score of 17 or more).
  • Sufficient understanding of English (spoken and written).
  • Ability to give informed consent

Exclusion Criteria:

  • Clinical judgement of high level of suicide risk, other risk to self or others requiring other urgent approaches e.g. admission to mental health unit.
  • Other severe mental illness e.g. psychosis, bipolar disorder, substance use disorder or organic mental disorder e.g. secondary to head injury as the primary mental health problem as determined by a structured psychiatric interview (SCID).
  • Currently receiving structured psychological therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PS CBT

Problem solving cognitive behaviour therapy (PS CBT) will be delivered remotely by means of telephone or video calling by a cognitive behaviour therapist in addition to their usual care.

The duration of the intervention will be 10 sessions. Research measures will be completed at baseline, 3,6,9 and 12 months

NO_INTERVENTION: Treatment as Usual
Participants will not receive any CBT therapy in addition to their usual care. Research measures will be completed at baseline,3,6,9 and 12 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory (V2)
Time Frame: Baseline to 6 months
The difference of change in self-rated depression as measured by Beck depression inventory (version 2) from baseline to 6 months, between the control and intervention group.
Baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory (V2)
Time Frame: Baseline to 12 months
Baseline to 12 months
Time to Self-Harm
Time Frame: Baseline to 12 months
Time to self-harm, assessed through a self-report measure and verified through medical records where possible
Baseline to 12 months
Patient Health Questionnaire 9
Time Frame: Baseline to 12 months
Depressive symptoms on the PHQ-9 (Kroenke et al, 2001)
Baseline to 12 months
Beck hopelessness scale
Time Frame: Baseline to 12 months
Hopelessness measured on the Beck hopelessness scale (Beck, 1988)
Baseline to 12 months
Columbia Suicide Severity Rating Scale
Time Frame: Baseline to 12 months
Suicidality measured on the Columbia Suicide Severity Rating Scale (CSSRS; Posner et al, 2011).
Baseline to 12 months
Social functioning
Time Frame: Baseline to 12 months
Social functioning measured using the work and social adjustment scale (WSAS; Mundt et al, 2002).
Baseline to 12 months
Quality of life
Time Frame: Baseline to 12 months
Quality of life measured using EQ-5D (EuroQol Group, 1990).
Baseline to 12 months
Cost Effectiveness
Time Frame: Baseline to 12 months
A modified version of the Client Service Receipt Inventory (CSRI; Beecham & Knapp, 2001): to measure costs, service utilisation, income and related matters to analyse cost effectiveness.
Baseline to 12 months
Qualitative Interviews
Time Frame: Baseline to 12 months
Explore reasons why individuals may or may not engage with the study and the PS CBT intervention
Baseline to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kapil Sayal, PhD, CLAHRC-EM, University of Nottingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (ACTUAL)

December 1, 2016

Study Completion (ACTUAL)

December 1, 2016

Study Registration Dates

First Submitted

February 25, 2015

First Submitted That Met QC Criteria

February 25, 2015

First Posted (ESTIMATE)

March 3, 2015

Study Record Updates

Last Update Posted (ACTUAL)

January 17, 2018

Last Update Submitted That Met QC Criteria

January 16, 2018

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CLAHRC-EM 14059

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe